Oaklins' professionals understand the regulatory, reimbursement, technological, medical and patient environments locally and around the world. We know the key players and can take a global perspective on any M&A deal. We identify the right strategic partners, maximize synergy potential and realize premium valuations for our clients. That's the Oaklins way.

Global Deals

Tombstone image
Tombstone image
Tombstone image
Tombstone image
Tombstone image

Oaklins Healthcare Specialists


South Africa, Johannesburg

Yaron Zimbler


Canada, Montreal

Pierre Mathieu

Mexico, Mexico City

Alejandro Rocha

United States, Chicago

Arthur J. Lyman

United States, Cleveland

Andrew P. Male

United States, Jacksonville

Daniel Edelman

United States, Los Angeles

Jonathan Bluth

United States, New York

Michael S. Goldman

United States, Seattle

Scott Hardman

Asia Pacific

Australia, Sydney

Peter Fraser

China, Hong Kong

Adrian Bradbury

China, Shanghai

John Zhang

Japan, Tokyo

Taro Okayama

Singapore, Singapore

Alistair Burgoyne

Europe and Middle East

Austria, Vienna

Markus F. Bläuel

Belgium, Brussels

Nathalie Van Den Haute

Croatia, Zagreb

Željko Perić

Czech Republic, Prague

David Tajzich

Denmark, Copenhagen

Frederik Aakard

Estonia, Tallinn

Lauri Isotamm

Finland, Helsinki

Mikael Planting

France, Lyon

Francisco Diez

France, Paris

Pierre Dropsy

Germany, Hamburg

Christian Jellentrup

Ireland, Dublin

David Lyons

Israel, Tel Aviv

Boaz Levi

Italy, Milan

Marco A. Vismara

Latvia, Riga

Anna Aile

Lithuania, Vilnius

Šarūnas Skyrius

Netherlands, Amsterdam

Robert Boersma

Norway, Oslo

Odd Paulsen

Poland, Warsaw

Maciej Szalaj

Russia, Moscow

Alexey Bykov

Slovakia, Bratislava

Michal Staron

Spain, Madrid

José Antonio Martín de los Santos

Sweden, Stockholm

Sven-Åke Lewin

Switzerland, Bern

Roberto Tracia

Turkey, Istanbul

Levent Bosut

United Kingdom, London

Amanda Phillips

United Kingdom, London

Michael Jewell


Leading medical nitinol tubing manufacturer joins medical contract manufacturing platform

DEAL FLASH: Oaklins’ team in Germany and healthcare specialist in New York have advised the shareholders of Vascotube GmbH, a global manufacturer of high quality nitinol tubing, on the sale of the company to 3i-backed Cirtec Medical Systems, LLC. This acquisition aligns with Cirtec’s strategy to vertically integrate and expand its capabilities in minimally invasive interventional therapies. Read more about the transaction, market trends, deal…


Market leader and industry pioneer in genetic diagnostics acquired by global medical technology company

DEAL FLASH: Oaklins’ team in Los Angeles has advised the shareholders of Ambry Genetics Corporation, a clinical diagnostics testing services provider, on the sale of the company to Konica Minolta, Inc. This powerful combination will bring the most comprehensive genetic diagnostic solutions to Japan, Europe and globally. Read more about the transaction, market trends, deal drivers and M&A valuation aspects.


Oaklins’ team in Russia will join SFM Group at the BIO 2017

Our client, SFM Group, is going to attend the world’s largest global biotechnology event BIO 2017 International Convention taking place from 19–22 June 2017 in San Diego, USA. SFM Group, is an innovative Russian pharmaceutical company specializing in pharma R&D and has its own production facilities. Its product portfolio includes medicines to treat cardio-vascular diseases, viral infections, regenerative medicines, etc. Its breakthrough product is Trombovazim, a powerful thrombolytic…


Globalizing cutting edge technology in point-of-care patient blood management

DEAL FLASH: Oaklins’ team in Switzerland advised the shareholders of TEM Group on the sale of the company to Instrumentation Laboratory (IL). The team acted as lead advisor to the shareholders of TEM Group throughout the sale process. This deal demonstrates the value and competitive advantage Oaklins provides in guiding the client in a very close personal relationship through all stages of the process. Read…


Shareholder succession at Sphinx Werkzeuge AG

The owners of Sphinx Werkzeuge AG have sold a majority stake in the company to Helvetica Capital AG and members of the management team. Financial details were not disclosed. Sphinx Werkzeuge is a leading precision tools developer and manufacturer for high precision mechanical and medical applications. The company’s core business is the production of micro to small drills. In the medical technology industry, its products…


Instrumentation Laboratory Acquires CA CASYSO AG, Including TEM® subsidiaries and ROTEM® Testing Systems

Instrumentation Laboratory (IL) acquired CA Casyso AG (Basel, Switzerland) and its Tem subsidiaries (Tem), a global leader in in vitro diagnostic (IVD) testing for Patient Blood Management (PBM) with their flagship ROTEM testing systems. Tem is a global leader in in-vitro-diagnostic (IVD) testing for Patient Blood Management (PBM) with their flagship ROTEM testing systems. With a direct sales force in seven markets, including the US,…


A new rehabilitation pathway for acquired brain injuries

DEAL FLASH:  Smith & Williamson advised the shareholders of Oakleaf Care (Hartwell) Limited (Oakleaf) on the sale of the company to CareTech Holdings Plc (CareTech). Oakleaf provides brain injury rehabilitation to adult males requiring specialist care and long-term support. The in-depth healthcare sector knowledge and experience of our team of advisors was crucial to achieving a successful sale. Read more about the transaction, market trends,…


Cross-border deal in biosimilars

HEALTHCARE DEAL FLASH:  Oaklins’ Swedish and Italian teams advised the shareholders of Xbrane Biosciences AB (Xbrane) on the acquisition of Primm Pharma. They supported the buyer by scouting the Italian market, identifying the most suitable target, and assisting in the LOI formulation and in negotiations throughout the process. Through the acquisition, Xbrane will be able to broaden their expertise within the field of high demand…


Consolidation continues in the dental industry

HEALTHCARE DEAL FLASH:  Our Oaklins’ team in the Netherlands and Cavendish, an Oaklins member firm in the UK, advised the shareholders of C.D.C. Complete tandzorg (CDC) in the sale of a stake in the company to G Square Healthcare Private Equity. The partnership will enable CDC to expand its dental care services to other regions in the Netherlands by opening new dental practices. Read more…